Welcome to Dementias Platform UK

Detection. Treatment. Prevention.

A scientist takes a vial of blood from a selection of blood test samples

Diadem partners with DPUK to advance Alzheimer’s diagnosis and treatment

Diadem SpA, a company developing AlzoSure Predict, the first blood-based test for the early prediction of progression to Alzheimer’s disease, has joined DPUK as an industry partner.

Screengrab of the front page of the DPUK Data Portal

DPUK Data Portal passes 1,000 cohort access requests

Researchers have made more than 1,000 applications to access cohorts within the DPUK Data Portal. The milestone study is using MEG data from the BioFIND imaging cohort to identify pre-dementia changes in the brain.

A group of children playing, holding hands in a circle

Study finds childhood deprivation is linked to faster cognitive decline

Our circumstances and experiences in childhood can have lasting consequences for our thinking skills, according to a new study funded by DPUK.

A colourful graphic of the brain with glowing lights around it.

Does the brain's immune system hold the key to treating dementia?

There is a growing collection of evidence that neuroinflammation may play an important role in the progression of dementia. Read our blog post to find out more.

Image showing a selection of pills and medicines

DPUK Director signs open letter calling for dementia 'medicines taskforce'

DPUK Director Professor John Gallacher has co-signed an open letter to the UK prime minister calling for greater investment in dementia research, taking inspiration from the COVID-19 vaccines effort.

A photo of the people involved in the Inspire Fund grant: Dr Sarah Bauermeister, Tim Parrynew and Feyi Raimi-Abraham, plus the ARUK and DPUK logos.

New art workshops to improve diversity in dementia research

DPUK has been awarded a £23,000 grant from Alzheimer's Research UK's Inspire Fund, which supports public engagement initiatives to improve understanding of dementia and dementia research.

Learn about DPUK's Experimental Medicine Incubator

Podcast: Professor James Rowe explains how DPUK's Experimental Medicine Incubator is supporting clinical research that aims to reduce the time, cost and risk of drug development.

About DPUK

DPUK brings together the best scientific minds and global leaders in the pharmaceutical industry to find new ways of detecting, treating and preventing dementia.

Our data-driven platform gives scientists fast access to findings, technology and volunteers – powering research to stop dementia in its tracks.

More about DPUK

Our research

Stylised image of the world featuring connecting dots

The DPUK Data Portal gives researchers rapid, secure access to millions of health research records.

More about the Data Portal

A group of older people smiling after exercising

Our Trials Delivery Framework matches public volunteers to the right dementia studies.

More about the TDF

Our Experimental Medicine Incubator accelerates and de-risks the development of new treatments.

More about the EMI

Research highlights

Dr Emma Elliott and Dr Terry Quinn from the University of Glasgow team

Featured research: Could drugs that manage heart disease be used to treat dementia?

DPUK researchers at the University of Glasgow are searching for heart disease medications that may have the side-effect of treating dementia.

Find out more

Featured researcher: Dr Ludovica Griffanti

DPUK grant winner Dr Ludovica Griffanti, of Oxford University's Wellcome Centre for Integrative Neuroimaging, is developing a method of synchronising brain scan measurements using large datasets.

Find out more

Work with us

Would you like to increase the international visibility of your data? Try our Data Portal.

Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.

Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.

Contact DPUK